Preoperative Chemoradiotherapy With Cetuximab in Rectal Cancer
NCT00506844
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
40
Enrollment
OTHER_GOV
Sponsor class
Conditions
Rectal Neoplasms
Neoadjuvant Treatment
Interventions
DRUG:
Cetuximab, Irinotecan, Capecitabine
Sponsor
National Cancer Center, Korea